401 related articles for article (PubMed ID: 33830321)
1. Vascular endothelial injury assessed with functional techniques in systemic sclerosis patients with pulmonary arterial hypertension versus systemic sclerosis patients without pulmonary arterial hypertension: a systematic review and meta-analysis.
Theodorakopoulou MP; Minopoulou I; Sarafidis P; Kamperidis V; Papadopoulos C; Dimitroulas T; Boutou AK
Rheumatol Int; 2021 Jun; 41(6):1045-1053. PubMed ID: 33830321
[TBL] [Abstract][Full Text] [Related]
2. Nailfold Capillaroscopy in Systemic Sclerosis Patients with and without Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis.
Minopoulou I; Theodorakopoulou M; Boutou A; Arvanitaki A; Pitsiou G; Doumas M; Sarafidis P; Dimitroulas T
J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33917407
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary arterial hypertension in systemic sclerosis is associated with profound impairment of microvascular endothelium-dependent vasodilatation.
Hofstee HM; Voskuyl AE; Vonk Noordegraaf A; Smulders YM; Postmus PE; Dijkmans BA; Serné EH
J Rheumatol; 2012 Jan; 39(1):100-5. PubMed ID: 22174212
[TBL] [Abstract][Full Text] [Related]
4. Nailfold capillaroscopic changes in patients with idiopathic pulmonary arterial hypertension and systemic sclerosis-related pulmonary arterial hypertension.
Corrado A; Correale M; Mansueto N; Monaco I; Carriero A; Mele A; Colia R; Di Biase M; Cantatore FP
Microvasc Res; 2017 Nov; 114():46-51. PubMed ID: 28619664
[TBL] [Abstract][Full Text] [Related]
5. Nailfold Videocapillaroscopy in Systemic Sclerosis-related Pulmonary Arterial Hypertension: A Systematic Literature Review.
Smith V; Vanhaecke A; Vandecasteele E; Guerra M; Paolino S; Melsens K; Cutolo M
J Rheumatol; 2020 Jun; 47(6):888-895. PubMed ID: 31416927
[TBL] [Abstract][Full Text] [Related]
6. Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.
De Angelis R; Riccieri V; Cipolletta E; Del Papa N; Ingegnoli F; Bosello S; Spinella A; Pellegrino G; de Pinto M; Papa S; Armentaro G; Giuggioli D
Rheumatology (Oxford); 2024 May; 63(6):1616-1623. PubMed ID: 37624917
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of nailfold videocapillaroscopy in systemic sclerosis secondary pulmonary arterial hypertension: a meta-analysis.
Xia Z; Wang G; Xiao H; Guo S; Liu Y; Meng F; Liu D; Li G; Zong L
Intern Med J; 2018 Nov; 48(11):1355-1359. PubMed ID: 29761614
[TBL] [Abstract][Full Text] [Related]
8. Peripheral microvascular function is linked to cardiac involvement on cardiovascular magnetic resonance in systemic sclerosis-related pulmonary arterial hypertension.
Vos JL; Lemmers JMJ; El Messaoudi S; Snoeren M; van Dijk APJ; Duijnhouwer AL; Rodwell L; van Leuven SI; Post MC; Vonk MC; Nijveldt R
Eur Heart J Cardiovasc Imaging; 2024 Apr; 25(5):708-717. PubMed ID: 38170546
[TBL] [Abstract][Full Text] [Related]
9. Screening for the early detection of pulmonary arterial hypertension in patients with systemic sclerosis: A systematic review and meta-analysis of long-term outcomes.
Brown Z; Proudman S; Morrisroe K; Stevens W; Hansen D; Nikpour M
Semin Arthritis Rheum; 2021 Jun; 51(3):495-512. PubMed ID: 33857705
[TBL] [Abstract][Full Text] [Related]
10. Whole blood viscosity in systemic sclerosis: a potential biomarker of pulmonary hypertension?
Senturk B; Akdeniz B; Yilmaz MB; Ozcan Kahraman B; Acar B; Uslu S; Birlik M
Clin Rheumatol; 2020 Jan; 39(1):49-56. PubMed ID: 31129792
[TBL] [Abstract][Full Text] [Related]
11. The prevalence and incidence rate of pulmonary arterial hypertension in systemic sclerosis: Systematic review and meta-analysis.
Rubio-Rivas M; Homs NA; Cuartero D; Corbella X
Autoimmun Rev; 2021 Jan; 20(1):102713. PubMed ID: 33197579
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamic Response to Treatment and Outcomes in Pulmonary Hypertension Associated With Interstitial Lung Disease Versus Pulmonary Arterial Hypertension in Systemic Sclerosis: Data From a Study Identifying Prognostic Factors in Pulmonary Hypertension Associated With Interstitial Lung Disease.
Chauvelot L; Gamondes D; Berthiller J; Nieves A; Renard S; Catella-Chatron J; Ahmad K; Bertoletti L; Camara B; Gomez E; Launay D; Montani D; Mornex JF; Prévot G; Sanchez O; Schott AM; Subtil F; Traclet J; Turquier S; Zeghmar S; Habib G; Reynaud-Gaubert M; Humbert M; Cottin V
Arthritis Rheumatol; 2021 Feb; 73(2):295-304. PubMed ID: 32892515
[TBL] [Abstract][Full Text] [Related]
13. Differences in Right Ventricular Functional Changes during Treatment between Systemic Sclerosis-associated Pulmonary Arterial Hypertension and Idiopathic Pulmonary Arterial Hypertension.
Argula RG; Karwa A; Lauer A; Gregg D; Silver RM; Feghali-Bostwick C; Schanpp LM; Egbert K; Usher BW; Ramakrishnan V; Hassoun PM; Strange C
Ann Am Thorac Soc; 2017 May; 14(5):682-689. PubMed ID: 28282243
[TBL] [Abstract][Full Text] [Related]
14. Nailfold videocapillaroscopic changes in patients with pulmonary arterial hypertension associated with connective tissue diseases.
Arvanitaki A; Giannakoulas G; Triantafyllidou E; Pagkopoulou E; Boutou A; Garyfallos A; Karvounis H; Dimitroulas T
Rheumatol Int; 2021 Jul; 41(7):1289-1298. PubMed ID: 33978819
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: A systematic review and meta-analysis.
Zhang Y; Qin D; Qin L; Yang X; Luo Q; Wang H
Joint Bone Spine; 2022 Mar; 89(2):105287. PubMed ID: 34601113
[TBL] [Abstract][Full Text] [Related]
16. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the validation status of quality of life and functional disability measures in pulmonary arterial hypertension related to systemic sclerosis: results of a systematic literature analysis by the Expert Panel on Outcomes Measures in Pulmonary Arterial Hypertension related to Systemic Sclerosis (EPOSS).
Kowal-Bielecka O; Avouac J; Pittrow D; Huscher D; Behrens F; Denton CP; Foeldvari I; Humbert M; Matucci-Cerinic M; Nash P; Opitz CF; Rubin LJ; Seibold JR; Strand V; Furst DE; Distler O;
J Rheumatol; 2011 Nov; 38(11):2419-27. PubMed ID: 21965635
[TBL] [Abstract][Full Text] [Related]
18. Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se.
Lindholm A; Hesselstrand R; Rådegran G; Arheden H; Ostenfeld E
Clin Physiol Funct Imaging; 2019 May; 39(3):215-225. PubMed ID: 30597705
[TBL] [Abstract][Full Text] [Related]
19. Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.
Sanges S; Rice L; Tu L; Valenzi E; Cracowski JL; Montani D; Mantero JC; Ternynck C; Marot G; Bujor AM; Hachulla E; Launay D; Humbert M; Guignabert C; Lafyatis R
Ann Rheum Dis; 2023 Mar; 82(3):365-373. PubMed ID: 36600187
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension.
Di Benedetto P; Guggino G; Manzi G; Ruscitti P; Berardicurti O; Panzera N; Grazia N; Badagliacca R; Riccieri V; Vizza CD; Radchenko G; Liakouli V; Ciccia F; Cipriani P; Giacomelli R
Arthritis Res Ther; 2020 Jun; 22(1):127. PubMed ID: 32487240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
